Clinical Trials Logo

Clinical Trial Summary

Objective: investigators investigated the effects of metoprolol tartrate plus Tongmai Yangxin Pill on premature ventricular complexes and cardiac function in patients with premature ventricular complex. Methods: In total, 584 participants with premature ventricular complex will be randomly assigned (at a 1:1 ratio) into two groups: study group (metoprolol tartrate [25 mg twice per day, orally] plus Tongmai Yangxin Pill [40 pills twice per day, orally]) and control group (metoprolol tartrate [25 mg twice per day, orally] plus placebo [40 simulated pills twice per day, orally]). The total treatment period is 8 weeks. Efficacy endpoints and safety assessment: Primary efficacy endpoints are as follows: change in 24-h number of PVCs after treatment and effective rate of 24-h number of PVCs after treatment. Secondary efficacy endpoints are as follows: change in New York Heart Association classification; total effective rate of comprehensive effect; change in high-sensitivity C-reactive protein level; and change in echocardiography parameters (i.e., left ventricular ejection fraction, left ventricular end diastolic dimension, E/A, cardiac index, cardiac output, and stroke volume).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05008250
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact
Status Completed
Phase Phase 4
Start date January 2014
Completion date August 2016

See also
  Status Clinical Trial Phase
Completed NCT03370679 - The Prognostic Significance of Premature Ventricular Complexes in Patients Without Structural Heart Disease N/A
Completed NCT04884100 - enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening N/A
Not yet recruiting NCT04990089 - VIVO European Observational Registry
Not yet recruiting NCT06110364 - Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions Phase 3
Completed NCT04171479 - RMN Versus Manual Epicardial Retrospective PMCF
Not yet recruiting NCT04519112 - Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial Phase 4
Recruiting NCT01235156 - Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions Phase 2
Recruiting NCT05866731 - The Heart Rhythm Twins Study
Recruiting NCT04909528 - LLTS to Treat Premature Ventricular Contractions N/A
Not yet recruiting NCT06327425 - MCG for Localization of Tachyarrhythmia's Origin N/A
Completed NCT03340142 - VIVO™ Accuracy Study N/A
Completed NCT02666742 - DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation Phase 4
Completed NCT03447002 - Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex
Withdrawn NCT04219501 - Ventricular Arrhythmia Ablation With the Use of Non-Invasive ECG Imaging Technology N/A
Not yet recruiting NCT03086902 - Comparision of PVC Ablation Techniques N/A
Recruiting NCT05341544 - Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes N/A
Enrolling by invitation NCT01750775 - Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Phase 4
Completed NCT05167058 - Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm
Terminated NCT03288766 - SHERLOCK 3CG™ Diamond Tip Confirmation System